Clincosm LogoSign in Get a demo

hbv

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

Not yet recruiting
  • HBV
  • HCC
  • nucleoside analogues or interferon
  • Hefei, Anhui, China
  • +9 more
Jul 20, 2023

Hiv, Syphilis, HBV Trial (TRI-MOM intervention)

Not yet recruiting
  • Hiv
  • +2 more
  • TRI-MOM intervention
  • (no location specified)
Jul 10, 2023

Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV Trial in Guangzhou (Rifaximin 200 mg, Standard Treatment without

Recruiting
  • Liver Failure, Acute on Chronic
  • +5 more
  • Rifaximin 200 mg
  • Standard Treatment without Rifaximin
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
Mar 26, 2023

Early Diagnosis of Hepatocellular Carcinoma (HCC)

Recruiting
  • HCC
  • +4 more
  • Biomarker dosage
  • Castellana Grotte, Bari, Italy
    RCCS "Saverio de Bellis"
Mar 23, 2023

Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

Recruiting
  • HBV
  • Primary Liver Cancer
  • HBV DNA Sequencing
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 22, 2022

Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

Enrolling by invitation
  • Hepatitis B Reactivation
  • +3 more
  • Seoul, Korea, Republic of
    Jeong Won Jang
Dec 16, 2022

Hepatocellular Carcinoma, HBV Trial (Hepatect CP 50 I.E./ml infusion solution)

Not yet recruiting
  • Hepatocellular Carcinoma
  • HBV
  • Hepatect CP 50 I.E./ml infusion solution
  • (no location specified)
Nov 9, 2022

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

HBV Trial in Wuhan (hUCMSCs)

Recruiting
  • HBV
  • hUCMSCs
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 27, 2022

Access HBV Assays - European Union Clinical Trial Protocol -

Recruiting
  • HBV
  • Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays
  • Amiens, France
  • +4 more
Jun 23, 2022

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

Active, not recruiting
  • Human Immunodeficiency Virus
  • +6 more
  • Anti-HIV Agents
  • Lusaka, Zambia
    Centre for Infectious Disease Research in Zambia (CIDRZ)
Jun 1, 2022

Chronic Hepatitis B Virus Infection in Zambia

Active, not recruiting
  • HBV
  • +5 more
  • Standard of care
  • Lusaka, Zambia
    Tropical Gastroenterology and Nutrition Group
Jun 1, 2022

HBV, Chronic HBV Infection Trial in Worldwide (TAF, TDF, TAF Placebo)

Active, not recruiting
Has Results
  • HBV
  • Chronic HBV Infection
  • Los Angeles, California
  • +159 more
Mar 17, 2022

HBV, Chronic HBV Infections Trial in China (TAF, TDF, TAF Placebo)

Active, not recruiting
Has Results
  • HBV
  • Chronic HBV Infections
  • Beijing, China
  • +24 more
Mar 17, 2022

HBV Trial in Taichung (Antroquinonol, )

Recruiting
  • HBV
  • Taichung, Taiwan
    Chung Shan Medical University Hospital
Mar 14, 2022

Hepatic Decompensation and Survival Outcomes in Pediatric

Recruiting
  • Cirrhosis
  • +6 more
  • Prediction model
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jan 5, 2022

HCV, HBV, Hiv Trial in Paris (HCV, HBV, HIV tests)

Terminated
  • HCV
  • +2 more
  • HCV, HBV, HIV tests
  • Paris, France
    Lariboisière
Nov 19, 2021

Among Inflammation, Physical and Mental Health in Chronic

Recruiting
  • Chronic Infectious Disease
  • +7 more
    • Napoli, Italy
      Department of Psychiatry - University of Campania "Luigi Vanvite
    Nov 6, 2021

    HBV, POST LIVER TRANSPLANT Trial in Shanghai (Tenofovir Alafenamide 25 MG)

    Active, not recruiting
    • HBV
    • POST LIVER TRANSPLANT
    • Tenofovir Alafenamide 25 MG
    • Shanghai, Shanghai, China
      Zhongshan hospital, Fudan University
    Sep 22, 2021

    Cirrhosis, Liver, Vaccination Failure, HBV Trial (IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN)

    Not yet recruiting
    • Cirrhosis, Liver
    • +3 more
    • IMIQUIMOD cream
    • HEPATITIS B SURFACE ANTIGEN
    • (no location specified)
    Aug 27, 2021

    Hepatitis B, Chronic Hep B, HBV Trial in Guangzhou, Shanghai, Chengdu (APG-1387, Entecavir 0.5 mg)

    Recruiting
    • Hepatitis B
    • +2 more
    • Guangzhou, Guangdong, China
    • +3 more
    Aug 25, 2021

    HBV, Inflammatory Arthritis Trial (Tenofovir alafenamide)

    Not yet recruiting
    • HBV
    • Inflammatory Arthritis
    • Tenofovir alafenamide
    • (no location specified)
    Aug 5, 2021

    Kidney Transplantation, HBV Trial in Chengdu (prophylaxis regimen)

    Recruiting
    • Kidney Transplantation
    • HBV
    • prophylaxis regimen
    • Chengdu, Sichuan, China
      Tao Lin
    Jul 21, 2021

    HBV Trial in Tainan

    Recruiting
    • HBV
      • Tainan, Taiwan
        National Cheng-Kung University Hospital
      May 11, 2021

      HBV Trial in Paris (o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B)

      Recruiting
      • HBV
      • o receive treatment with anti-CD20 (rituximab or ocrelizumab) and to be vaccinated against hepatitis B
      • Paris, Ile De France, France
        Valérie POURCHER
      Feb 2, 2021